Alzamend Neuro, Inc. (ALZN)

Alzamend Neuro Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	4.45	3.95	0.38	5.14	14.06	1.93
Cash & Short-Term Investments	4.45	3.95	0.38	5.14	14.06	1.93
Cash Growth	8.71%	950.04%	-92.69%	-63.45%	628.97%	2036.87%
Other Receivables	-	-	-	-	-	0.02
Receivables	-	-	-	-	-	0.02
Prepaid Expenses	0.27	0.23	0.08	0.69	0.35	0.97
Total Current Assets	4.72	4.18	0.46	5.84	14.41	2.91
Property, Plant & Equipment	0.37	0.43	0.18	0.08	0.1	-
Total Assets	5.09	4.6	0.63	5.92	14.52	2.91
Accounts Payable	0.72	0.63	2.93	2.87	1.16	0.5
Short-Term Debt	-	-	0.3	-	-	0.34
Other Current Liabilities	-	-	-	-	0	0.06
Total Current Liabilities	0.72	0.63	3.23	2.87	1.16	0.9
Total Liabilities	0.72	0.63	3.23	2.87	1.16	0.9
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-In Capital	66.61	62.5	51.43	62	57.42	33.72
Retained Earnings	-62.24	-58.54	-54.02	-44.07	-29.19	-16.83
Comprehensive Income & Other	-	-	-	-14.88	-14.88	-14.88
Total Common Equity	4.37	3.97	-2.59	3.05	13.35	2.01
Shareholders' Equity	4.37	3.97	-2.59	3.05	13.35	2.01
Total Liabilities & Equity	5.09	4.6	0.63	5.92	14.52	2.91
Total Debt	-	-	0.3	-	-	0.34
Net Cash (Debt)	4.45	3.95	0.08	5.14	14.06	1.59
Net Cash Growth	8.71%	5141.53%	-98.53%	-63.45%	782.32%	5671.48%
Net Cash Per Share	2.59	8.76	1.00	71.17	213.10	29.62
Filing Date Shares Outstanding	3.8	2.9	0.09	0.07	0.07	0.06
Total Common Shares Outstanding	3.8	0.78	0.08	0.07	0.07	0.05
Working Capital	4	3.54	-2.77	2.97	13.25	2.01
Book Value Per Share	1.15	5.10	-33.94	42.41	188.78	40.30
Tangible Book Value	4.37	3.97	-2.59	3.05	13.35	2.01
Tangible Book Value Per Share	1.15	5.10	-33.94	42.41	188.78	40.30

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q